| Old Articles: <Older 2421-2430 Newer> |
|---|
 |
InternetNews
October 14, 2005
Colin C. Haley |
Nanotech Battles Bird Flu Several nanotech and IT firms say their products could help detect the virus and slow its spread.   |
The Motley Fool
October 14, 2005
Stephen D. Simpson |
Boston's Stunts With Stents Tough domestic stent competition is weighing on results from one-trick pony Boston Scientific. The company is in a transitional period and that's at least part of why the stock is down where it is. |
The Motley Fool
October 14, 2005
Rich Duprey |
Chiron Ready to Fly Flu vaccine maker readies first shipments as flu season begins and avian flu fears rise. |
Pharmaceutical Executive
October 1, 2005 |
Bad Rep An interview with Jamie Reidy, who wrote the book on how to slack off as a pharma sales rep. Now, the sales manager's nightmare unveils more scams, sizes up the corporate selling culture -- and reveals what finally made him care. |
Pharmaceutical Executive
October 1, 2005
Glass & Worrell |
Whose Afraid of Authorized Generics Losing a patent challenge lets a generic competitor grab market share and slash branded profits. Sound scary? Ignoring authorized generics is worse. |
Pharmaceutical Executive
October 1, 2005
Mike Iafolla & Steve Greco |
Under the Influence The number of influences that affect physicians' prescribing has increased and rep saturation has reached the tipping point, resulting in "customer fatigue." Companies must now take into account a plethora of influences when planning their sales and marketing efforts. |
Pharmaceutical Executive
October 1, 2005 |
Changing Diabetes An interview with Novo Nordisk's president of U.S. operations Martin Soeters on how a nation that leads the world in diabetes research does such a poor job of treating it. Here, he offers some solutions. |
Pharmaceutical Executive
October 1, 2005
Elio Evangelista |
Pairing Up More pharmaceuticals are folding Competitive Intelligence departments into Market Research. Here's why that strategy makes sense -- and some hints on making the new relationship work. |
Pharmaceutical Executive
October 1, 2005
Lisa Grimes |
Clear Road Ahead An industry standard for publicizing clinical-trial results is a ways off. But pharma's openness to more transparent procedures is moving things in the right direction. |
Pharmaceutical Executive
October 1, 2005
Wade & St. Vrain |
Direct to Consumer: Perfect Package Pharmaceutical packaging can strengthen brand identity and increase patient loyalty and compliance. |
| <Older 2421-2430 Newer> Return to current articles. |
